China
Africa
Explore chapters and articles related to this topic
Nanomaterials-Based Wearable Biosensors for Healthcare
Published in Sibel A. Ozkan, Bengi Uslu, Mustafa Kemal Sezgintürk, Biosensors, 2023
Jose Marrugo-Ramírez, L. Karadurmus, Miguel Angel Aroca, Emily P. Nguyen, Cecilia de Carvalho Castro e Silva, Giulio Rosati, Johann F. Osma, Sibel A. Ozkan, Arben Merkoçi
Cardiovascular diseases: Cardiovascular diseases are a few of the many life-threatening statuses that can be detected and efficiently cured using the wearable sensor. Wearable sensors are distinctively used in the treatment of cardiovascular diseases. Cardiovascular disease (CVD) is a general nomenclature given to the group that includes diseases of the heart or blood vessels. Cardiovascular disease describes any disease that affects the circulatory system. These include numerous heart-related complications such as cardiac arrest, arrhythmia, congestive heart failure, coronary artery disease, etc. More than 17 million people die from CVDs each year, which is around 31% of all deaths worldwide. If the current situation is allowed to persist, it is estimated that by 2030, an estimated 23.6 million people will die from cardiovascular disease (33–39).
Hydrogels with Ubiquitous Roles in Biomedicine and Tissue Regeneration
Published in Harishkumar Madhyastha, Durgesh Nandini Chauhan, Nanopharmaceuticals in Regenerative Medicine, 2022
Priyanka, Pooja A Chawla, Aakriti, Viney Chawla, Durgesh Nandini Chauhan, Bharti Sapra
Heart failure is one of the critical diseases that causes maximum deaths globally. Heart transplantation is considered to be the unsurpassed treatment for the last-stage heart failure patients. Because of the restricted and inadequate repository of donor hearts (Barr and Taylor, 2015; Kikuchi and Poss, 2012; Macdonald et al., 2015; Prabhu and Frangogiannis, 2016) and the indigent regenerative ability of the myocardium, researchers have moved towards the therapeutic approaches which ameliorate myocardial function.
Nanomedicinal Genetic Manipulation: Promising Strategy to Treat Some Genetic Diseases
Published in Sarwar Beg, Mahfoozur Rahman, Md. Abul Barkat, Farhan J. Ahmad, Nanomedicine for the Treatment of Disease, 2019
Biswajit Mukherjee, Iman Ehsan, Debasmita Dutta, Moumita Dhara, Lopamudra Dutta, Soma Sengupta
Heart failure: The heart fails to pump sufficient blood, resulting in the deficient supply of blood to the organs. Heart failure is preceded by shortness of breath, muscle fatigue, edema of ankle, feet, and veins in the neck.
Optimal Adaptive Magnetic Suspension Control of Rotary Impeller for Artificial Heart Pump
Published in Cybernetics and Systems, 2022
Amjad J. Humaidi, Saleem Khalefa Kadhim, Ahmed Sharhan Gataa
The heart of human being is a muscle organ in the size of a hand fist, which and it is responsible for pumping the blood through the vessels of blood circulatory system (Paul 2005; Kadhim et al. 2017). According to the World Health Organization, the cardiovascular diseases are the number one cause of death globally. The heart failure usually occurs when its muscle does not work properly either due to narrowing in arteries, high pressure, abnormal heart valves, heart muscle disease, diabetes or severe lung disease. The repeated failure in human heart leads to the need for replacing the normal heart by artificial one, called as artificial heart (AH) ventricles (AHV) or left ventricle device. However, based on previous studies, it has been reported that 95% of patients with AH encounters failure in their implanted AH (Peter 1990).
Soft medical robotics: clinical and biomedical applications, challenges, and future directions
Published in Advanced Robotics, 2019
Jen-Hsuan Hsiao, Jen-Yuan (James) Chang, Chao-Min Cheng
When a patient is diagnosed with heart failure (HF), the heart cannot pump sufficient blood to maintain tissue perfusion. Decreased cardiac output may cause fluid overload, lower extremity swelling, and pulmonary edema. Common symptoms of heart failure include shortness of breath, general fatigue, and reduced ability to exercise. Those afflicted may seek heart transplantation, but with limited donors available, ventricular assist devices (VADs) and direct cardiac compression device (DCCs) are more frequent clinical approaches. VADs augment the function of the left and right ventricles of the heart by extracting blood from the ventricles before pumping it back to the heart [15]. However, blood flowing over the metallic surface of a VAD may coagulate and form blood clots, which could endanger the patient’s life [16]. DCCs, however, do not come in direct contact with blood. They are surgically placed around the beating heart to help provide sufficient blood flow. Although conventional DCCs could preclude the possibility of coagulation, proper adhesion and synchronization of the DCC with the natural pumping of the heart remains a challenge. These and other obstacles have motivated the development of soft cardiac devices [17] (Figure 1).